Beth Jantzen - Oct 17, 2025 Form 4 Insider Report for APPLIED DNA SCIENCES INC (BNBX)

Role
Chief Financial Officer
Signature
/s/ Beth Jantzen
Stock symbol
BNBX
Transactions as of
Oct 17, 2025
Transactions value $
$0
Form type
4
Date filed
10/20/2025, 05:03 PM
Previous filing
Mar 27, 2023
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Jantzen Beth Chief Financial Officer 50 HEALTH SCIENCES DRIVE, STONY BROOK /s/ Beth Jantzen 2025-10-20 0001633940

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BNBX Common Stock Award $0 +18.7K +623033.33% $0.00 18.7K Oct 17, 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 100% of the restricted stock units vest upon 90 days from the date of grant